Pulmonary hypertension due to COPD at high altitude

A. S. Sarybaev, A. S. Sydykov, A. M. Maripov, M. M. Kasymov, M. M. Mirrakhimov (Bishkek, Kyrgyzstan)

Source: Annual Congress 2002 - High altitude and hypoxia
Session: High altitude and hypoxia
Session type: Thematic Poster Session
Number: 697
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. S. Sarybaev, A. S. Sydykov, A. M. Maripov, M. M. Kasymov, M. M. Mirrakhimov (Bishkek, Kyrgyzstan). Pulmonary hypertension due to COPD at high altitude. Eur Respir J 2002; 20: Suppl. 38, 697

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
State of β-adrenoreceptors in pulmonary hypertension due to COPD at high altitude
Source: Eur Respir J 2002; 20: Suppl. 38, 99s
Year: 2002

Endothelin and high altitude pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


High-altitude disease
Source: Respipedia Article
Year: 2017

Pulmonary hypertension reduces exercise tolerance in COPD
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010

Cerebral oxygenation in highlanders with high altitude pulmonary hypertension
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013


The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016


Common genetic basis for pulmonary arterial hypertension and high altitude pulmonary edema
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018

Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010


Prevalence of established and exercise induced pulmonary hypertension in COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011

Right and left ventricular function in lowlanders with COPD travelling to moderate altitude
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


Pulmonary hypertension at the patients with bronchial asthma and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 58s
Year: 2004

Pulmonary hypertension and exercise performance in advanced COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011


Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Pulmonary hypertension in COPD
Source: Eur Respir J 2008; 32: 1371-1385
Year: 2008



Pulmonary hypertension in a COPD Patient
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020


Pulmonary hypertension in COPD: Prevalence and characteristics
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012